Furlanello F, Pedrinazzi C, Inama G, De Ambroggi L, Cappato R
Arrhythmia and Electrophysiology Center, IRCCS Policlinico San Donato, San Donato Milanese, Milan, Italy.
Minerva Cardioangiol. 2008 Dec;56(6):659-66.
Atrial fibrillation (AF) is the most frequent cause of prolonged palpitations in young competitive athletes, even including those performing elite sport activity. This arrhythmia may occasionally affect impair athletes' ability to compete thus leading to non-eligibility at prequalification screening. Competitive sport has a significant impact on the autonomous nervous system. In fact, long-term regular intense physical training determines an increase in vagal tone leading to resting bradycardia. During physical activity, particularly in the setting of competition, a marked release of catecholamines occurs as a result of both the intense physical effort and emotional stress. Both of these adaptive phenomena may precipitate AF. Furthermore, in several athletes with AF an association with sick sinus syndrome has been found, even though the pathophysiological basis of this finding is not clear. This picture is further complicated by the increasingly intake of illicit substances, whose arrhythmogenic effect has been shown both at the ventricular and atrial levels. Moreover, the use of recreational drugs, such as amphetamines, ecstasy, alcohol, cannabinoids, cocaine and so called new drugs in clubs has dramatically increased, with several cases of drug-induced arrhythmic events. These effects are often exacerbated by the combined use of different drugs, especially in situations such as sports competitions, in which the adrenergic system is already hyperactivated. No data have been published on the efficacy of antiarrhythmic therapy in athletes with AF, but it has been reported that athletes are more predisposed to the development of pro-arrhythmic effects induced by antiarrhythmic drugs when compared to general population. Most recently, radiofrequency catheter ablation involving electrical disconnection of the pulmonary veins in athletes with AF limiting their normal training activity and participation in sports competitions has proven highly effective to restore stable sinus rhythm and enable subsequent re-eligibility.
心房颤动(AF)是年轻竞技运动员心悸持续时间延长的最常见原因,甚至包括那些从事精英体育活动的运动员。这种心律失常偶尔可能会影响运动员的比赛能力,从而导致他们在资格预审筛查中不符合参赛资格。竞技运动对自主神经系统有重大影响。事实上,长期有规律的高强度体育训练会导致迷走神经张力增加,进而引起静息性心动过缓。在体育活动期间,尤其是在比赛中,由于剧烈的体力消耗和情绪压力,儿茶酚胺会大量释放。这两种适应性现象都可能诱发房颤。此外,在一些房颤运动员中发现了与病态窦房结综合征的关联,尽管这一发现的病理生理基础尚不清楚。非法物质的摄入量不断增加使这种情况更加复杂,其致心律失常作用已在心室和心房水平得到证实。此外,在俱乐部中使用娱乐性药物,如苯丙胺、摇头丸、酒精、大麻、可卡因和所谓的新型毒品的情况急剧增加,出现了几例药物诱发的心律失常事件。不同药物的联合使用往往会加剧这些影响,尤其是在体育比赛等肾上腺素能系统已经过度激活的情况下。目前尚无关于抗心律失常治疗对房颤运动员疗效的数据,但据报道,与普通人群相比,运动员更容易受到抗心律失常药物诱发的促心律失常作用的影响。最近,对于限制正常训练活动和参加体育比赛的房颤运动员,采用射频导管消融术隔离肺静脉已被证明能非常有效地恢复稳定的窦性心律,并使他们随后有资格再次参赛。